Join DASON Clinical Pharmacist Liaison Jeannette Bouchard as she speaks with Dr. Nick Turner, lead author of the DOTS randomized clinical trial, about the potential of dalbavancin as a simplified treatment for Staphylococcus aureus bacteremia. They discuss the trial’s findings, its implications for clinical practice, and whether two doses can truly replace weeks of IV antibiotics. The materials reviewed in this episode can be found here: https://dason.medicine.duke.edu/blog/new-rules-old-infections-what-dots-trial-tells-us

For more information about DASON, please visit: https://dason.medicine.duke.edu

In this episode, Dr. Melissa Johnson, one of our DASON Clinical Pharmacist Liaisons, talks with Dr. Kim Claeys, from the University of Maryland, about her recent work on the implementation diagnostic stewardship to improve UTI antibiotic use. The two publications referenced in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/40720743/ and here: https://pubmed.ncbi.nlm.nih.gov/37424224/

For more information about DASON, please visit: https://dason.medicine.duke.edu/

In this episode of the DASON Digest podcast, DASON Clinical Pharmacist Liaison, Dr. April Dyer, talks to us about an article in Antimicrobial Stewardship & Healthcare Epidemiology entitled "Implementation and performance of a nurse administered modified PEN-FAST clinical decision rule in the electronic health record." The article can be found here: https://pubmed.ncbi.nlm.nih.gov/40697885/

For more information about DASON, please visit: https://dason.medicine.duke.edu/